| Agent |
Mechanism of Action |
Route |
Effect on PDPH |
Adverse Effects |
| Opioids |
Interact with opioid receptors in the central nervous system. |
Oral/IV |
Pain relief |
Nausea and Vomiting |
| Caffeine |
Central nervous system stimulant, reversibly blocks cerebral adenosine receptors which lead to vasoconstriction of dilated cerebral blood vessels. |
Oral/IV (300 - 500 mg) once or twice daily. Single oral dose for mild PDPH was proved to be safe [47] . Caffeine Sodium Benzoate as an IV Bolus/Infusion was proved to be 75% - 80% effective [48] |
Temporary pain relief |
Return of headache 48 hr after the IV administered dose |
| Sumatriptan |
Serotonin type 1-d receptor agonist, vasoconstriction of intracranial blood vessels. |
Subcutaneous |
Variable results: a few case reports have reported improvement of symptoms [49] while clinical trials have proved inefficacy [50] [51] |
Pain at the site of injection Chest tightness Caution in patients with Ischemic Heart Disease Expensive drug |